P

Inventor

GANESAN RAJKUMAR

US33 patents
⚠️ This page may combine multiple inventors who share the name “GANESAN RAJKUMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN BIOTECH INC

23 patents
US11667712B2Jun 6, 2023

Materials and methods for modulating t cell mediated immunity

JANSSEN BIOTECH INC2 citations72
US12077592B2Sep 3, 2024

GPRC5D chimeric antigen receptors and cells expressing the same

JANSSEN BIOTECH INC3 citations69
US12180278B2Dec 31, 2024

Antibody targeting CD22 and CD79B

JANSSEN BIOTECH INC2 citations68
US12084501B2Sep 10, 2024

Proteins comprising CD3 antigen binding domains and uses thereof

JANSSEN BIOTECH INC2 citations66
US12129310B2Oct 29, 2024

Materials and methods for enhanced linker targeting

JANSSEN BIOTECH INC0 citations62
US11639396B2May 2, 2023

Antibody binding to a linker peptide

JANSSEN BIOTECH INC0 citations62
US12492226B2Dec 9, 2025

Materials and methods for producing bioengineered virus specific lymphocytes

JANSSEN BIOTECH INC0 citations61
US11981932B2May 14, 2024

Materials and methods for the manufacture of pluripotent stem cells

JANSSEN BIOTECH INC1 citations61
US12492256B2Dec 9, 2025

Methods and compositions for modulating beta chain mediated immunity

JANSSEN BIOTECH INC0 citations59
US12448449B2Oct 21, 2025

Immune targeting molecules and uses thereof

JANSSEN BIOTECH INC0 citations59
US12264197B2Apr 1, 2025

Anti-Vβ17/anti-CD123 bispecific antibodies

JANSSEN BIOTECH INC0 citations59
US11965024B2Apr 23, 2024

Methods and compositions for modulating beta chain mediated immunity

JANSSEN BIOTECH INC0 citations59
US12077585B2Sep 3, 2024

Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses

JANSSEN BIOTECH INC0 citations58
US11866499B2Jan 9, 2024

Monospecific and multispecific anti-TMEFF2 antibodies and their uses

JANSSEN BIOTECH INC0 citations57
US12460001B2Nov 4, 2025

Proteins comprising CD3 antigen binding domains and uses thereof

JANSSEN BIOTECH INC0 citations54
US11952411B2Apr 9, 2024

Materials and methods of using engineered ligands

JANSSEN BIOTECH INC0 citations54
US12076413B2Sep 3, 2024

Compositions and methods for modulating delta gamma chain mediated immunity

JANSSEN BIOTECH INC0 citations49
US11926667B2Mar 12, 2024

Bioengineered T cell mediated immunity, materials and other methods for modulating cluster of differentiation IV and/or VIII

JANSSEN BIOTECH INC0 citations49
US12071466B2Aug 27, 2024

Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereof

JANSSEN BIOTECH INC0 citations46
US12522658B2Jan 13, 2026

Anti-CD79 chimeric antigen receptors, CAR-T cells, and uses thereof

JANSSEN BIOTECH INC0 citations43
US12134658B2Nov 5, 2024

Materials and methods for multidirectional biotransportation in virotherapeutics

JANSSEN BIOTECH INC0 citations41
US12103977B2Oct 1, 2024

Trispecific antibody targeting CD79b, CD20, and CD3

JANSSEN BIOTECH INC0 citations41
US11827708B2Nov 28, 2023

Proteins comprising HLA-G antigen binding domains and their uses

JANSSEN BIOTECH INC0 citations41

BOEHRINGER INGELHEIM INT

6 patents

GANESAN RAJKUMAR

3 patents

JANSSEN PHARMACEUTICA NV

1 patent